Diffusion volume (DV) measurement in endometrial and cervical cancer: A new MRI parameter in the evaluation of the tumor grading and the risk classification

被引:33
作者
Mainenti, Pier Paolo [1 ]
Pizzuti, Laura Micol [1 ]
Segreto, Sabrina [2 ]
Comerci, Marco [1 ]
De Fronzo, Simona [2 ]
Romano, Federica [2 ]
Crisci, Vincenzina [2 ]
Smaldone, Michele [2 ]
Laccetti, Ettore [2 ]
Storto, Giovanni [3 ]
Alfano, Bruno [1 ]
Maurea, Simone [2 ]
Salvatore, Marco [4 ]
Pace, Leonardo [5 ]
机构
[1] IBB CNR, Naples, Italy
[2] Univ Naples Federico II, Sez Radiol, Dipartimento Sci Biomed Avanzate, Naples, Italy
[3] IRCCS CROB, Rionero, Italy
[4] IRCCS SDN, Naples, Italy
[5] Univ Salerno, Dipartimento Med & Chirurg, I-84100 Salerno, Italy
关键词
MRI; DWI; ADC maps; Diffusion volume; Cervical; Endometrial; Cancer; FIGO STAGING SYSTEM; WEIGHTED MRI; MYOMETRIAL INVASION; FDG PET; COEFFICIENT; BODY; CONCORDANCE; CARCINOMA;
D O I
10.1016/j.ejrad.2015.10.014
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: A new MRI parameter representative of active tumor burden is proposed: diffusion volume (DV), defined as the sum of all the voxels within a tumor with apparent diffusion coefficient (ADC) values within a specific range. The aims of the study were: (a) to calculate DV on ADC maps in patients with cervical/endometrial cancer; (b) to correlate DV with histological grade (G) and risk classification; (c) to evaluate intra/inter-observer agreement of DV calculation. Materials and methods: Fifty-three patients with endometrial (n = 28) and cervical (n = 25) cancers underwent pelvic MRI with DWI sequences. Both endometrial and cervical tumors were classified on the basis of G (G1/G2/G3) and FIGO staging (low/medium/high-risk). A semi-automated segmentation procedure was used to calculate the DV. A freehand closed ROI outlined the whole visible tumor on the most representative slice of ADC maps defined as the slice with the maximum diameter of the solid neoplastic component. Successively, two thresholds were generated on the basis of the mean and standard deviation (SD) of the ADC values: lower threshold (LT="mean minus three SD") and higher threshold (HT = "mean plus one SD"). The closed ROI was expanded in 3D, including all the contiguous voxels with ADC values in the range LT-HT x 10-3 mm(2)/s. A Kruskal-Wallis test was used to assess the differences in DV among G and risk groups. Intra-/inter-observer variability for DV measurement was analyzed according to the method of Bland and Altman and the intraclass-correlation-coefficient (ICC). Results: DV values were significantly different among G and risk groups in both endometrial (p < 0.05) and cervical cancers (p <= 0.01). For endometrial cancer, DV of G1 (mean +/- sd: 2.81 +/- 3.21 cc) neoplasms were significantly lower than G2 (9.44 +/- 9.58 cc) and G3 (11.96 +/- 8.0 cc) ones; moreover, DV of low risk cancers (5.23 +/- 8.0 cc) were significantly lower than medium (7.28 +/- 4.3 cc) and high risk (14.7 +/- 9.9 cc) ones. For cervical cancer, DV of G1 (0.31 +/- 0.13 cc) neoplasms was significantly lower than G3 (40.68 +/- 45.65 cc) ones; moreover, DV of low risk neoplasms (6.98 +/- 8.08 cc) was significantly lower than medium (21.7 +/- 17.13 cc) and high risk (62.9 +/- 51.12 cc) ones and DV of medium risk neoplasms was significantly lower than high risk ones. The intra-/inter-observer variability for DV measurement showed an excellent correlation for both cancers (ICC >= 0.86). Conclusions: DV is an accurate index for the assessment of G and risk classification of cervical/endometrial cancers with low intra-/inter-observer variability. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:113 / 124
页数:12
相关论文
共 38 条
[1]   MR diffusion imaging for preoperative staging of myometrial invasion in patients with endometrial cancer: a systematic review and meta-analysis [J].
Andreano, Anita ;
Rechichi, Gilda ;
Rebora, Paola ;
Sironi, Sandro ;
Valsecchi, Maria Grazia ;
Galimberti, Stefania .
EUROPEAN RADIOLOGY, 2014, 24 (06) :1327-1338
[2]   FIGO Staging System for Endometrial Cancer: Added Benefits of MR Imaging [J].
Beddy, Peter ;
O'Neill, Ailbhe C. ;
Yamamoto, Adam K. ;
Addley, Helen C. ;
Reinhold, Caroline ;
Sala, Evis .
RADIOGRAPHICS, 2012, 32 (01) :241-254
[3]   Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET [J].
Berkowitz, Arnold ;
Basu, Sandip ;
Srinivas, Shyam ;
Sankaran, Shrinkanthan ;
Schuster, Stephen ;
Alavi, Abass .
NUCLEAR MEDICINE COMMUNICATIONS, 2008, 29 (06) :521-526
[4]   Diffusion-weighted imaging in the assessment of tumour grade in endometrial cancer [J].
Bharwani, N. ;
Miquel, M. E. ;
Sahdev, A. ;
Narayanan, P. ;
Malietzis, G. ;
Reznek, R. H. ;
Rockall, A. G. .
BRITISH JOURNAL OF RADIOLOGY, 2011, 84 (1007) :997-1004
[5]   Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography [J].
Bos, R ;
van der Hoeven, JJM ;
van der Wall, E ;
van der Groep, P ;
van Diest, PJ ;
Comans, EFI ;
Joshi, U ;
Semenza, GL ;
Hoekstra, OS ;
Lammertsma, AA ;
Molthoff, CFM .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) :379-387
[6]   Apparent diffusion coefficient of diffusion weighted MRI in endometrial carcinoma-Relationship with local invasiveness [J].
Cao, Kun ;
Gao, Min ;
Sun, Ying-Shi ;
Li, Yan-Ling ;
Sun, Yu ;
Gao, Yu-Nong ;
Zhang, Xiao-Peng .
EUROPEAN JOURNAL OF RADIOLOGY, 2012, 81 (08) :1926-1930
[7]   Correlation between serum CEA level and metabolic volume as determined by FDG PET in postoperative patients with recurrent colorectal cancer [J].
Choi, MY ;
Lee, KM ;
Chung, JK ;
Lee, DS ;
Jeong, JM ;
Park, JG ;
Kim, JH ;
Lee, MC .
ANNALS OF NUCLEAR MEDICINE, 2005, 19 (02) :123-129
[8]   Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer [J].
Chung, Hyun Hoon ;
Kim, Jae Weon ;
Han, Kyung Hee ;
Eo, Jae Seon ;
Kang, Keon Wook ;
Park, Noh-Hyun ;
Song, Yong-Sang ;
Chung, June-Key ;
Kang, Soon-Beom .
GYNECOLOGIC ONCOLOGY, 2011, 120 (02) :270-274
[9]   Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Colombo, N. ;
Carinelli, S. ;
Colombo, A. ;
Marini, C. ;
Rollo, D. ;
Sessa, C. .
ANNALS OF ONCOLOGY, 2012, 23 :27-32
[10]   Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Colombo, N. ;
Preti, E. ;
Landoni, F. ;
Carinelli, S. ;
Colombo, A. ;
Marini, C. ;
Sessa, C. .
ANNALS OF ONCOLOGY, 2011, 22 :vi35-vi39